SIG Brokerage’s Axsome Therapeutics AXSM Stock Holding History

SIG Brokerage’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$388K	Buy	+2,298	New	+$397K	0.01%	600

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIG Brokerage's AXSM Position: Q1 2026 in Review

SIG Brokerage opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 2,298 shares worth $388K. The stake represents 0.01% of the portfolio and ranks #600 among its holdings.

409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

SIG Brokerage held 2,298 shares of Axsome Therapeutics worth $388K as of Q1 2026.
Axsome Therapeutics was a new SIG Brokerage position in Q1 2026.
Axsome Therapeutics made up 0.01% of SIG Brokerage's portfolio in Q1 2026, its #600 holding.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.